About This Event
Avalyn Pharma (Nasdaq: AVLN), visits the Nasdaq MarketSite in Times Square. The company is advancing optimized inhaled formulations of established antifibrotic medicines with the aim of transforming the treatment paradigm for pulmonary fibrosis and other serious, rare respiratory diseases.
In honor of the occasion, Lyn Baranowski, CEO, rings the Opening Bell.